Does the Public Prefer Health Gain for Cancer Patients? A Systematic Review of Public Views on Cancer and its Characteristics

Does the Public Prefer Health Gain for Cancer Patients? A Systematic Review of Public Views on... PharmacoEconomics (2017) 35:793–804 DOI 10.1007/s40273-017-0511-7 SYSTEMATIC REVIEW Does the Public Prefer Health Gain for Cancer Patients? A Systematic Review of Public Views on Cancer and its Characteristics 1 2,3 4 1 • • • Liz Morrell Sarah Wordsworth Sian Rees Richard Barker Published online: 29 April 2017 The Author(s) 2017. This article is an open access publication Abstract while the other found no such preference but provided Background Policies such as the Cancer Drugs Fund in results consistent with population health maximisation. England assumed a societal preference to fund cancer care Other studies mostly showed support for cancer but did not relative to other conditions, even if that resulted in lower require a direct health trade-off. Severity and end-of-life health gain for the population overall. searches identified 12 and 6 papers, respectively, which Objective The aim of this study was to investigate the were additional to existing reviews. There is consistent evidence for such a preference among the UK public. evidence that people give priority to severe illness, while Methods The MEDLINE, PubMed and Econlit electronic results for end-of-life are mixed. databases were searched for studies relating to preferences Conclusion We did not find consistent support for a pref- http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png PharmacoEconomics Springer Journals

Does the Public Prefer Health Gain for Cancer Patients? A Systematic Review of Public Views on Cancer and its Characteristics

Loading next page...
 
/lp/springer_journal/does-the-public-prefer-health-gain-for-cancer-patients-a-systematic-KmTUggze0k
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by The Author(s)
Subject
Medicine & Public Health; Pharmacoeconomics and Health Outcomes; Quality of Life Research; Health Economics; Health Administration; Public Health
ISSN
1170-7690
eISSN
1179-2027
D.O.I.
10.1007/s40273-017-0511-7
Publisher site
See Article on Publisher Site

Abstract

PharmacoEconomics (2017) 35:793–804 DOI 10.1007/s40273-017-0511-7 SYSTEMATIC REVIEW Does the Public Prefer Health Gain for Cancer Patients? A Systematic Review of Public Views on Cancer and its Characteristics 1 2,3 4 1 • • • Liz Morrell Sarah Wordsworth Sian Rees Richard Barker Published online: 29 April 2017 The Author(s) 2017. This article is an open access publication Abstract while the other found no such preference but provided Background Policies such as the Cancer Drugs Fund in results consistent with population health maximisation. England assumed a societal preference to fund cancer care Other studies mostly showed support for cancer but did not relative to other conditions, even if that resulted in lower require a direct health trade-off. Severity and end-of-life health gain for the population overall. searches identified 12 and 6 papers, respectively, which Objective The aim of this study was to investigate the were additional to existing reviews. There is consistent evidence for such a preference among the UK public. evidence that people give priority to severe illness, while Methods The MEDLINE, PubMed and Econlit electronic results for end-of-life are mixed. databases were searched for studies relating to preferences Conclusion We did not find consistent support for a pref-

Journal

PharmacoEconomicsSpringer Journals

Published: Apr 29, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off